Globus Medical, Inc. (GMED)
Pre-market:
| Previous close | 51.36 |
| Open | 58.20 |
| Bid | 52.00 x 800 |
| Ask | 0.00 x 800 |
| Day's range | 58.20 - 65.74 |
| 52-week range | 43.39 - 65.74 |
| Volume | |
| Avg. volume | 1,149,419 |
| Market cap | 8.337B |
| Beta (5Y monthly) | 1.11 |
| PE ratio (TTM) | 114.31 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Globus Medical Reports First Quarter 2024 Results
AUDUBON, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2024. Worldwide net sales were $606.7 million, an increase of 119.3%, or 119.8% on a constant currency basisGAAP net loss for the quarter was $7.1 millionGAAP diluted earnings per share (“EPS”) was ($0.05) and non-GAAP diluted EPS was $0.72Non-GAAP adjusted EBITDA was $166.6 million, or 27.5% of net sa
- GlobeNewswire
Globus Medical Schedules First Quarter Earnings Release and Conference Call
AUDUBON, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, May 7, 2024. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com. Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m.
- GlobeNewswire
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
AUDUBON, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ended December 31, 2023. Fourth Quarter 2023: Worldwide net sales were $616.5 million, an increase of 124.6%, or 123.8% on a constant currency basisGAAP net income for the quarter was $15.0 millionGAAP diluted earnings per share (“EPS”) was $0.11 and non-GAAP diluted EPS was $0.60Non-GAAP adjusted EB
